Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABUS compared with OMEX: revenue, margins and what each company keeps, and the suppliers and customers both name
ABUS
Arbutus Biopharma Corp
Change
Mkt cap
Revenue
Revenue
OMEX
Odyssey Marine Exploration Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABUS
Arbutus Biopharma Corp
vs
OMEX
Odyssey Marine Exploration Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ABUS
0 of 3
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
—
▼
−1.71%
—
May 13 '26
±6.5%
0.00%
×0.00
Q1 FY26
±13.7%
▲
+4.25%
×0.31
Q3 FY25
±22.5%
▼
−5.79%
×0.26
OMEX
No earnings history for OMEX.
= implied
ABUS realized, solid
OMEX realized, hatched
One scale, both sides: full bar = 23%
× = |realized| ÷ implied
Source: market data
ABUS
Arbutus Biopharma Corp
Change
4.20
▼
−1.82%
· post 4.20
Mkt cap
$832.9M
Revenue
$1M
Q2 FY26
Revenue
$14M
FY25
OMEX
Odyssey Marine Exploration Inc
Change
13.50
▲
+2.74%
· post 10.70
Closed
Oct 30 '26
Mkt cap
$26.5M
Revenue
$77,855
Q2 FY26
Revenue
$353,719
FY25
vs
Compare
Closed
Oct 30 '26
ABUS
Arbutus Biopharma Corp
vs
OMEX
Odyssey Marine Exploration Inc
4.20
▼
−1.82%
post 4.20
Price
13.50
▲
+2.74%
post 10.70
$832.9M
Mkt cap
$26.5M
Q2 FY26
$1M
Revenue
$77,855
Q2 FY26
FY25
$14M
Revenue
$353,719
FY25
Change
Change
ABUS
4.20
▼
−1.82%
vs
OMEX
13.50
▲
+2.74%
Closed
Oct 30 '26